The EMBO Journal,
Journal Year:
2023,
Volume and Issue:
42(17)
Published: July 10, 2023
Abstract
Accumulating
evidence
indicates
that
gut
microbiota
dysbiosis
is
associated
with
increased
blood–brain
barrier
(BBB)
permeability
and
contributes
to
Alzheimer's
disease
(AD)
pathogenesis.
In
contrast,
the
influence
of
on
blood‐cerebrospinal
fluid
(CSF)
has
not
yet
been
studied.
Here,
we
report
mice
lacking
display
blood‐CSF
disorganized
tight
junctions
(TJs),
which
can
be
rescued
by
recolonization
or
supplementation
short‐chain
fatty
acids
(SCFAs).
Our
data
reveal
important
only
for
establishment
but
also
maintenance
a
barrier.
Also,
vagus
nerve
plays
an
role
in
this
process
SCFAs
independently
tighten
Administration
App
NL‐G‐F
improved
subcellular
localization
TJs
at
barrier,
reduced
β‐amyloid
(Aβ)
burden,
affected
microglial
phenotype.
Altogether,
our
results
suggest
modulating
administering
might
have
therapeutic
potential
AD
via
tightening
maintaining
activity
Aβ
clearance.
Science,
Journal Year:
2021,
Volume and Issue:
374(6571), P. 1087 - 1092
Published: Nov. 25, 2021
The
brain
and
gastrointestinal
tract
are
critical
sensory
organs
responsible
for
detecting,
relaying,
integrating,
responding
to
signals
derived
from
the
internal
external
environment.
At
interface
of
this
function,
immune
cells
in
intestines
consistently
survey
environmental
factors,
eliciting
responses
that
inform
on
physiological
state
body.
Recent
research
reveals
cross-talk
along
gut-brain
axis
regulates
inflammatory
nociception,
responses,
homeostasis.
Here,
we
discuss
molecular
cellular
mechanisms
involved
signaling
inflammation
across
axis.
We
further
highlight
interactions
between
gut
inflammation-associated
diseases.
Biomedicine & Pharmacotherapy,
Journal Year:
2021,
Volume and Issue:
139, P. 111661 - 111661
Published: May 8, 2021
During
the
past
decade,
accumulating
evidence
from
research
highlights
suggested
effects
of
bacterial
communities
human
gut
microbiota
and
their
metabolites
on
health
disease.
In
this
regard,
microbiota-derived
receptors,
beyond
immune
system,
maintain
metabolism
homeostasis,
which
is
essential
to
host's
by
balancing
utilization
intake
nutrients.
It
has
been
shown
that
dysbiosis
can
cause
pathology
altered
metabolites'
formation,
resulting
in
dysregulation
system
metabolism.
The
short-chain
fatty
acids
(SCFAs),
such
as
butyrate,
acetate,
succinate,
are
produced
due
fermentation
process
bacteria
gut.
noted
remodeling
associated
with
pathophysiology
several
neurological
disorders,
Alzheimer's
disease,
multiple
sclerosis,
Parkinson's
amyotrophic
lateral
stress,
anxiety,
depression,
autism,
vascular
dementia,
schizophrenia,
stroke,
neuromyelitis
optica
spectrum
among
others.
This
review
will
discuss
current
most
significant
studies
dealing
some
SCFAs
microbial
selected
disorders.
Frontiers in Neuroscience,
Journal Year:
2019,
Volume and Issue:
13
Published: Dec. 18, 2019
The
link
between
gut
microbiome
and
brain
is
being
slowly
acknowledged
due
to
the
speculated
role
of
resident
microbial
community
in
altering
functions
gut-brain
axis
(GBA).
Recently,
a
number
metabolites
(referred
as
neuro-active
metabolites)
produced
through
tryptophan
metabolism
have
been
suggested
influence
GBA.
In
view
this,
current
study
focuses
on
pathways
which
produce
metabolites.
An
silico
analysis
was
performed
bacterial
genomes
well
publicly
available
data.
results
provide
comprehensive
catalog
analyzed
across
bacteria.
indicates
an
enrichment
five
gut-associated
phyla,
namely,
Actinobacteria,
Firmicutes,
Bacteroidetes,
Proteobacteria,
Fusobacteria.
Further,
genera,
Clostridium,
Burkholderia,
Streptomyces,
Pseudomonas,
Bacillus
predicted
be
enriched
terms
pathways,
suggesting
higher
potential
these
groups
metabolize
gut.
Analysis
data
corresponding
samples
from
patients
neurological
diseases
healthy
individuals
suggests
probable
association
different
sets
metabolizing
with
etiology
diseases.
insights
obtained
present
are
expected
directions
toward
designing
based
diagnostic
therapeutic
approaches
for
diseases/disorders.
Brain Research Bulletin,
Journal Year:
2022,
Volume and Issue:
182, P. 44 - 56
Published: Feb. 11, 2022
Depression
is
the
most
common
mental
disorder
and
a
leading
cause
of
disability
worldwide.
Despite
abundant
research,
precise
mechanisms
underlying
pathophysiology
depression
remain
elusive.
Accumulating
evidence
from
preclinical
clinical
studies
suggests
that
alterations
in
gut
microbiota,
microbe-derived
short-chain
fatty
acids,
D-amino
acids
metabolites
play
key
role
via
brain–gut–microbiota
axis,
including
neural
immune
systems.
Notably,
axis
might
crucial
susceptibility
versus
resilience
rodents
exposed
to
stress.
Vagotomy
reported
block
depression-like
phenotypes
after
fecal
microbiota
transplantation
"depression-related"
microbiome,
suggesting
vagus
nerve
influences
through
axis.
In
this
article,
we
review
recent
findings
regarding
discuss
its
potential
as
therapeutic
target
for
depression.
Microbiome,
Journal Year:
2022,
Volume and Issue:
10(1)
Published: April 29, 2022
Altered
intestinal
microbiota
composition
in
later
life
is
associated
with
inflammaging,
declining
tissue
function,
and
increased
susceptibility
to
age-associated
chronic
diseases,
including
neurodegenerative
dementias.
Here,
we
tested
the
hypothesis
that
manipulating
influences
development
of
major
comorbidities
aging
and,
particular,
inflammation
affecting
brain
retina.
Journal of Advanced Research,
Journal Year:
2021,
Volume and Issue:
38, P. 223 - 244
Published: Sept. 17, 2021
Recent
research
on
the
implications
of
gut
microbiota
brain
functions
has
helped
to
gather
important
information
relationship
between
them.
Pathogenesis
neurological
disorders
is
found
be
associated
with
dysregulation
gut-brain
axis.
Some
bacteria
metabolites
are
directly
increase
in
reactive
oxygen
species
levels,
one
most
risk
factors
neurodegeneration.
Besides
their
morbid
association,
also
play
a
significant
role
reducing
onset
these
life-threatening
disorders.Studies
done
recent
past
raises
two
link
and
brain:
"gut
microbiota-oxidative
stress-neurodegeneration"
microbiota-antioxidant-neuroprotection.
This
review
aims
gives
deep
insight
our
readers,
collective
studies
done,
focusing
mediated
oxidative
stress
involved
neurodegeneration
along
focus
those
showing
involvement
neuroprotection.This
focused
three
main
key
concepts.
Firstly,
mounting
evidences
from
clinical
preclinical
arenas
shows
influence
resulting
dysfunctional
processes.
Therefore,
we
describe
potential
influencing
vulnerability
stress,
budding
causative
Alzheimer's
Parkinson's
disease.
Secondly,
contributing
roles
been
observed
attenuating
inflammation
via
its
own
or
by
producing
secondary
and,
modulation
population
antioxidative
anti-inflammatory
probiotics
have
shown
promising
neuro
resilience.
Thirdly,
high
throughput
silico
tools
databases
correlation
microbiome,
health,
thus
providing
fascinating
perspective
new
avenues
for
therapeutic
options.
Nutrients,
Journal Year:
2021,
Volume and Issue:
13(3), P. 732 - 732
Published: Feb. 25, 2021
In
the
last
decade,
emerging
evidence
has
reported
correlations
between
gut
microbiome
and
human
health
disease,
including
those
affecting
brain.
We
performed
a
systematic
assessment
of
available
literature
focusing
on
bacterial
metabolites
their
associations
with
diseases
central
nervous
system
(CNS).
The
short-chain
fatty
acids
(SCFAs)
as
well
non-SCFAs
like
amino
acid
(AAMs)
amyloids
are
described
in
particular.
found
significantly
altered
SCFA
levels
patients
autism
spectrum
disorder
(ASD),
affective
disorders,
multiple
sclerosis
(MS)
Parkinson’s
disease
(PD).
Non-SCFAs
yielded
less
distinct
changes
faecal
healthy
controls,
majority
findings
were
derived
from
urinary
blood
samples.
Preclinical
studies
have
implicated
different
potentially
beneficial
detrimental
mechanisms
brain
diseases.
Examples
include
immunomodulation
catecholamine
production
by
histone
deacetylase
inhibition,
anti-inflammatory
effects
through
activity
aryl
hydrocarbon
receptor
involvement
protein
misfolding.
Overall,
our
highlight
existence
across
various
diseases,
potential
neuroactive
which
gut-derived
SCFAs,
p-cresol,
indole
derivatives
could
impact
development
progression.
summarized
this
review
lead
to
further
insights
into
gut–brain–axis
thus
diagnostic,
therapeutic
or
preventive
strategies
Frontiers in Medicine,
Journal Year:
2022,
Volume and Issue:
9
Published: March 31, 2022
Over
the
last
10
years,
there
has
been
a
growing
interest
in
relationship
between
gut
microbiota,
brain,
and
neurologic-associated
affections.
As
multiple
preclinical
clinical
research
studies
highlight
microbiota’s
potential
to
modulate
general
state
of
health
state,
it
goes
without
saying
that
microbiota
plays
significant
role
neurogenesis,
mental
cognitive
development,
emotions,
behaviors,
progression
neuropsychiatric
illnesses.
Gut
produces
important
biologic
products
that,
through
gut-brain
axis,
are
directly
connected
with
appearance
evolution
neurological
psychiatric
disorders
such
as
depression,
anxiety,
bipolar
disorder,
autism,
schizophrenia,
Parkinson’s
disease,
Alzheimer’s
dementia,
sclerosis,
epilepsy.
This
study
reviews
recent
on
link
microbiome’s
shaping
development
most
common
Moreover,
special
attention
is
paid
use
probiotic
formulations
non-invasive
therapeutic
opportunity
for
prevention
management
neuropsychiatric-associated